Research
Powerful new weight-loss drug helps patients cut knee pain in half
The Brief
- An experimental weight-loss drug, retatrutide, helped people with knee osteoarthritis lose about 25% of their body weight at the highest dose.
- Roughly two-thirds of participants experienced at least a 50% reduction in knee pain.
Why it matters
The results suggest that weight-loss drugs could become a treatment option for knee osteoarthritis pain, not only for obesity. Readers in medicine and drug development should watch whether these findings hold up in further trials.
Who’s affected
- people with knee osteoarthritis
- clinicians and researchers in obesity and osteoarthritis treatment
- #osteoarthritis
- #weight loss
- #retatrutide
- #clinical trial
- #knee pain
A powerful experimental weight-loss drug helped people with knee osteoarthritis lose about 25% of their body weight at the highest dose, while roughly two-thirds experienced at least a 50% reduction in knee pain. The findings suggest retatrutide could transform treatment for…